Core Laboratories (CLB) Fundamental Analysis: Revenue, Earnings & Valuation

4.55 / 10

Netural

Fundamentals rate neutral with a 4.5/10 score. Strengths include Asset‑MV, PB‑ROE, cash‑to‑market ratios and revenue growth, while net‑asset growth and diluted ROE lag. Overall, the fundamentals are modest and warrant a guarded outlook.

Analysis Checks(6/10)

Net assets per share (growth rate compared to beginning of year %)

Value9.16

Score0/3

Weight1.30%

1M Return1.22%

Total operating revenue (YoY growth rate %)

Value0.51

Score3/3

Weight8.36%

1M Return6.53%

Net income-Revenue

Value-1.04

Score1/3

Weight13.50%

1M Return9.76%

PB-ROE

Value0.19

Score3/3

Weight19.55%

1M Return11.07%

Cash-UP

Value-0.46

Score1/3

Weight13.69%

1M Return8.09%

Net cash flow from operating activities / Total liabilities (%)

Value0.12

Score3/3

Weight8.67%

1M Return6.84%

ROE (diluted) (%)

Value11.37

Score0/3

Weight0.30%

1M Return0.29%

Operating revenue (YoY growth rate %)

Value0.51

Score3/3

Weight8.36%

1M Return6.53%

Asset-MV

Value-0.48

Score2/3

Weight8.50%

1M Return6.35%

Cash-MV

Value-1.17

Score3/3

Weight17.78%

1M Return12.56%

Is CLB undervalued or overvalued?

CLB scores 4.55/10 on fundamentals and holds a Fair valuation at present. Backed by its 11.31% ROE, 5.77% net margin, 24.60 P/E ratio, 2.68 P/B ratio, and -4.48% earnings growth, these metrics solidify its Netural investment rating.